Her primary scientific interests are in Genetics, Genome-wide association study, Single-nucleotide polymorphism, Alzheimer's disease and PICALM. Her Genetics research includes themes of Case-control study and Late onset. She interconnects Molecular genetics and Human genetics in the investigation of issues within Late onset.
Her Genome-wide association study study integrates concerns from other disciplines, such as Cerebellum, Progressive supranuclear palsy, Temporal cortex and Linkage disequilibrium. Her Single-nucleotide polymorphism research incorporates themes from Odds ratio, Apolipoprotein E and Age of onset. Minerva M. Carrasquillo combines subjects such as Common disease-common variant, TREM2, Dementia, Human brain and Regulation of gene expression with her study of Alzheimer's disease.
Her scientific interests lie mostly in Genetics, Disease, Genome-wide association study, Alzheimer's disease and Gene. Her work in Single-nucleotide polymorphism, Locus, Haplotype, Allele and PICALM is related to Genetics. Her Single-nucleotide polymorphism research is multidisciplinary, incorporating perspectives in Odds ratio and Age of onset.
Her Disease research integrates issues from Computational biology, Immunology and Bioinformatics. Her research in Genome-wide association study intersects with topics in Temporal cortex, Case-control study, Genetic association, Apolipoprotein E and Candidate gene. Her study in Alzheimer's disease is interdisciplinary in nature, drawing from both TREM2, Dementia and Oncology.
Minerva M. Carrasquillo mainly investigates Disease, Computational biology, Gene, Gene expression and Neuropathology. Her research integrates issues of Neurology, Immune system and Bioinformatics in her study of Disease. Her Computational biology research also works with subjects such as
Her studies in Gene integrate themes in fields like Cell type and Vascular risk. The various areas that she examines in her Neuropathology study include Biomarker, Genome-wide association study and Immunology. Genome-wide association study is a primary field of her research addressed under Genetics.
Minerva M. Carrasquillo focuses on Computational biology, Genome-wide association study, Disease, Gene and Meta-analysis. Her Computational biology research incorporates elements of Exon, Cell type, Human genetics and Human genome. The Genome-wide association study study combines topics in areas such as Immunology, PICALM and Microglia.
Her work carried out in the field of Disease brings together such families of science as Epistasis, Genetics and Autopsy. Many of her research projects under Gene are closely connected to Molecular medicine with Molecular medicine, tying the diverse disciplines of science together. She combines Alzheimer's disease and Hippocampal sclerosis in her research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj.
Nature Genetics (2013)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Denise Harold;Richard Abraham;Paul Hollingworth;Rebecca Sims.
Nature Genetics (2009)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro;Rita Guerreiro;Aleksandra Wojtas;Jose Bras;Minerva Carrasquillo.
The New England Journal of Medicine (2013)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish.
Nature Genetics (2011)
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang.
Nature Genetics (2011)
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.
Valentina Escott-Price;Céline Bellenguez;Li-San Wang;Seung-Hoan Choi.
PLOS ONE (2014)
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.
Lesley Jones;Peter A. Holmans;Marian L. Hamshere;Denise Harold.
PLOS ONE (2010)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez.
Nature Genetics (2017)
High-Throughput Variation Detection and Genotyping Using Microarrays
David J. Cutler;Michael E. Zwick;Minerva M. Carrasquillo;Christopher T. Yohn.
Genome Research (2001)
Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease
Minerva M Carrasquillo;Fanggeng Zou;V Shane Pankratz;Samantha L Wilcox.
Nature Genetics (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
University of Nottingham
Mayo Clinic
University of Pennsylvania
Lancaster University
Nielsen (United States)
University of Milano-Bicocca
University of Bristol
Inserm
Gladstone Institutes
Swedish University of Agricultural Sciences
National University of Ireland, Galway
University of Oslo
Imperial College London
Boston University
TU Dresden
University of Washington
University of Southern California
Memorial Sloan Kettering Cancer Center
Harvard University